This full-day multidisciplinary conference was designed for psychologists, social workers, counselors, physicians and other healthcare workers seeking to make sense of the rapidly evolving world of psychedelic-assisted therapy. In 2024, psychedelics dominated the headlines—with bold claims about the transformative potential of ketamine, psilocybin, and MDMA, an FDA rebuff of MDMA, and psychedelic-related referenda that both passed and failed. Meanwhile, continuing education events of uncertain quality have been popping up like mushrooms, leaving many clinicians wondering how to separate hype from evidence. No worries—we have you covered!

Featured presenters include: Alan Davis, PhD; Dylan McKenney, MD; Selma Holden, MD; and Shauna Sedler, PMHNP. This conference will provide an exploration of the field with one foot in the current science and the other foot in experience and clinical wisdom. Topics include the clinical use of ketamine, the role of set, setting, and ritual in psychedelic therapy, and how to integrate these treatments responsibly into mental health care. Attendees will leave with a deeper understanding of the scientific, legal, and practical aspects of psychedelic therapy and what the future holds for this controversial but promising field.

Fee includes continental breakfast and lunch.